TuisLBTSF • OTCMKTS
add
Almirall SA
Vorige sluiting
$15,35
Jaarwisseling
$13,36 - $15,47
Markkapitalisasie
2,76 mjd EUR
Gemiddelde volume
3,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
BME
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 310,56 m | 19,71% |
Bedryfskoste | 326,76 m | 24,35% |
Netto inkomste | 7,05 m | 139,36% |
Netto winsgrens | 2,27 | 99,12% |
Wins per aandeel | — | — |
EBITDA | 44,93 m | 42,47% |
Effektiewe belastingkoers | 24,54% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 337,77 m | -10,48% |
Totale bates | 2,34 mjd | -2,48% |
Totale aanspreeklikheid | 850,00 m | -6,42% |
Totale ekwiteit | 1,49 mjd | — |
Uitstaande aandele | — | — |
Prys om te bespreek | — | — |
Opbrengs op bates | 0,75% | — |
Opbrengs op kapitaal | 0,98% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 7,05 m | 139,36% |
Kontant van bedrywe | 28,16 m | -48,49% |
Kontant van beleggings | -22,64 m | -40,25% |
Kontant van finansiering | -44,35 m | -867,52% |
Netto kontantverandering | -38,83 m | -214,39% |
Beskikbare kontantvloei | 5,64 m | 133,50% |
Meer oor
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Gestig
1944
Webwerf
Werknemers
2 108
